Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
about
Autoimmune liver serology: current diagnostic and clinical challengesDetection of liver kidney microsomal type 1 antibody using molecularly based immunoassaysAutoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the diseaseAutoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infectionLiver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitisAutoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitisAutoimmune hepatitis and sclerosing cholangitis.Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays.The role of vitamin d in autoimmune hepatitisAntibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver diseaseOverlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes
P2860
Q24644140-4998650D-61F5-4977-9562-D6302CBEDC35Q24672941-29ADC573-5E65-4A19-9075-09C45206B444Q24804699-7D5CA09E-73B0-41AD-9E58-8BC3806977B5Q27480424-EFF924E4-C4E1-4862-A242-23E23226F21AQ30846833-492C6ED5-38E5-4DA5-BE02-0BFC40B198A3Q35351021-CF072636-D382-431B-A5EC-32056CAD5224Q35633205-EB1C54D3-5CCD-4FD9-B0B9-5819318EAF57Q35934744-B0D58226-48F8-403E-8CFD-F235E501B605Q36955214-D96F264C-AA00-4C91-8376-4E3D6B94172EQ38156439-80CE6AC0-BE67-408E-A7D2-F5824468BD72Q44488879-E2E7335B-8034-4347-BBCC-2F507B034D34Q57062009-0AF545ED-29C7-4C40-B2DB-350E3A329ECCQ58100731-7FB7F006-28CF-482F-B1A1-7386BFB42284
P2860
Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Establishment of a novel radio ...... d hepatitis C virus infection.
@en
type
label
Establishment of a novel radio ...... d hepatitis C virus infection.
@en
prefLabel
Establishment of a novel radio ...... d hepatitis C virus infection.
@en
P2093
P1476
Establishment of a novel radio ...... d hepatitis C virus infection.
@en
P2093
Bianchi FB
Gregorio G
Mieli-Vergani G
Muratori L
P304
P356
10.1016/S0168-8278(97)80477-1
P577
1997-06-01T00:00:00Z